A new educational program for scientists working on substance use disorder
MIT Open Learning team awarded NIH grant to provide training in biomedical product development, entrepreneurship, and innovation.
MIT researchers develop an AI model that can detect future lung cancer risk
Deep-learning model takes a personalized approach to assessing each patient’s risk of lung cancer based on CT scans.
Nanosensors target enzymes to monitor and study cancer
By analyzing enzyme activity at the organism, tissue, and cellular scales, new sensors could provide new tools to clinicians and cancer researchers.
New test may predict Covid-19 immunity
The paper test measures the level of neutralizing antibodies in a blood sample and could help people decide what protections they should take against infection.
Emma Gibson: Optimizing health care logistics in Africa
The PhD student seeks to improve patient care by helping facilities use their limited resources more effectively.
Advocating for vaccine equity
Postdoc Digbijay Mahat became a cancer researcher to improve health care in Nepal, but the Covid-19 pandemic exposed additional resource disparities.
SMART researchers develop method for early detection of bacterial infection in crops
The Raman spectroscopy-based method enables early detection and quantification of pathogens in plants, to enhance plant disease management.
New 10-minute test detects Covid-19 immunity
Paper-based blood test developed by SMART researchers can rapidly determine the presence of SARS-CoV-2 neutralizing antibodies.
Diagnosing cancer with a barcode-inspired test
Dana Al-Sulaiman, a recent postdoc with MIT’s Ibn Khaldun Fellowship for Saudi Arabian Women, has developed a cheap, minimally invasive diagnostic test for cancer.
Carbon nanotube-based sensor can detect SARS-CoV-2 proteins
The technology could be developed as a rapid diagnostic for Covid-19 or other emerging pathogens.
New device can diagnose Covid-19 from saliva samples
The tabletop diagnostic yields results in an hour and can be programmed to detect variants of the SARS-CoV-2 virus.
Faster tracking of treatment responses
Biological sensors developed by MIT spinout Glympse Bio could help clinicians make decisions for individual patients.
Exhaled biomarkers can reveal lung disease
Specialized nanoparticles create a “breath signal” that could be used to diagnose pneumonia and other infectious or genetic diseases.
MIT team collaborates with 3M to develop rapid Covid-19 test
Company working with Sikes Lab to test feasibility of low-cost diagnostic that could be manufactured by the millions each day.
Making an impact through chemical engineering
Hadley Sikes designs simple-to-use diagnostic devices that could benefit patients around the world.